Management of Alcohol Withdrawal in Psychiatric Inpatient Setting
Benzodiazepines are the gold standard treatment for alcohol withdrawal syndrome in psychiatric inpatient settings, with lorazepam being the preferred agent given its intermediate duration and safety profile in this population. 1, 2
Core Pharmacological Management
First-Line Treatment: Benzodiazepines
Lorazepam is the optimal choice for psychiatric inpatient units because it:
- Has intermediate duration of action (safer than long-acting agents in monitored settings)
- Can be given PO, IV, or IM
- Is metabolized via glucuronidation (safer in liver dysfunction, common in alcohol use disorder)
- Starting dose: 1-4 mg PO/IV/IM every 4-8 hours 2
Alternative benzodiazepines include:
- Chlordiazepoxide: 25-100 mg PO every 4-6 hours (better seizure prevention but longer-acting) 2
- Diazepam: 5-10 mg PO/IV/IM every 6-8 hours (longest-acting, best for seizure prevention) 2
Use symptom-triggered dosing rather than fixed-schedule dosing to prevent drug accumulation and reduce total benzodiazepine exposure 1. However, the CIWA-Ar protocol has limitations in psychiatric settings where anxiety disorders and other psychiatric conditions can inflate scores 2. In psychiatric inpatients with comorbid conditions, consider a hybrid approach with scheduled low-dose benzodiazepines plus PRN dosing for breakthrough symptoms.
Critical Adjunctive Treatment
Thiamine 100-300 mg/day must be given to all patients before any glucose-containing IV fluids to prevent Wernicke encephalopathy 2. Continue for 2-3 months after withdrawal resolution 2.
Duration and Tapering
Limit benzodiazepine use to 10-14 days maximum due to abuse potential, particularly high in patients with alcohol use disorder 1. Taper dosing as withdrawal symptoms resolve, typically over 3-7 days 2.
Management of Specific Complications
Seizure Prevention
Long-acting benzodiazepines (chlordiazepoxide, diazepam) provide superior seizure prophylaxis 2. Carbamazepine 200 mg PO every 6-8 hours is an alternative for patients who cannot tolerate benzodiazepines 2.
Severe Agitation or Hallucinations
If benzodiazepines alone are insufficient:
- Haloperidol 0.5-5 mg PO/IM every 8-12 hours as adjunctive therapy only 2
- Critical caveat: Haloperidol lowers seizure threshold and should never be used as monotherapy for alcohol withdrawal 2
- Avoid in patients with Parkinson's disease or Lewy body dementia due to extrapyramidal side effects 3
Refractory Withdrawal
For benzodiazepine-resistant cases requiring escalation:
Essential Supportive Care
Beyond pharmacotherapy, provide:
- IV hydration and electrolyte correction (especially magnesium, potassium)
- Quiet, calm environment with minimal stimulation
- Frequent vital sign monitoring (every 2-4 hours initially)
- Assessment for concurrent medical conditions: head trauma, infection, GI bleeding, pancreatitis, hepatic encephalopathy 2, 6
Common Pitfalls to Avoid
Do not use benzodiazepines as monotherapy for alcohol withdrawal delirium with psychotic features - add haloperidol cautiously 2
Do not give glucose before thiamine - this precipitates acute Wernicke encephalopathy 2
Do not use antipsychotics alone - they are less effective than benzodiazepines for preventing delirium (4.9 fewer cases per 100 patients with benzodiazepines, P=0.04) and seizures (7.7 fewer seizures per 100 patients, P=0.003) 7
Do not continue benzodiazepines beyond 10-14 days - high abuse potential in this population 1
Do not rely solely on CIWA-Ar scores in psychiatric patients - comorbid anxiety, panic disorder, and other psychiatric conditions artificially elevate scores 2
Transition to Long-Term Treatment
Once acute withdrawal is managed (typically 3-7 days), transition focus to relapse prevention:
- Naltrexone for preventing return to heavy drinking 1, 8
- Acamprosate for maintaining abstinence 1, 8
- Cognitive behavioral therapy combined with pharmacotherapy 9
- Avoid routine antidepressants unless treating a distinct depressive disorder - they show no benefit for alcohol use disorder itself 10
Psychiatric consultation should be obtained for all alcohol withdrawal cases to evaluate acute management needs and establish long-term abstinence planning 2.